10.1016/S0014-5793(00)02324-3
10.1046/j.1365-2249.2001.01490.x
Babior BM, 1992, Neutrophil function as related to neutrophil–endothelial interactions, Nouv. Rev. Fr. Hematol., 34, 829
10.1016/S0002-9343(00)00481-2
10.1016/S0531-5565(98)00012-6
10.1016/S0014-5793(99)00717-6
10.1016/S0014-2999(00)00033-9
10.3109/08820139609059301
10.1016/S0021-9150(00)00575-X
10.1111/j.1749-6632.2000.tb06651.x
10.1016/S0369-8114(01)00143-2
Fulop T, 1985, Age‐dependent alterations of Fc receptor mediated effector functions of human polymorphonuclear leukocytes, Clin. Exp. Immunol., 61, 425
10.1016/0047-6374(85)90041-7
10.1016/S0171-2985(86)80011-0
10.1016/S0047-6374(96)01881-7
10.1111/j.1749-6632.2002.tb04656.x
10.1016/0165-2478(94)00064-6
10.1016/0014-5793(89)80231-5
10.1016/S0065-2776(02)80017-7
10.1182/blood-2003-04-1078
Hirokawa K, 1998, Principles and Practice of Geriatric Medicine, 35
10.1016/S0896-6273(04)00194-1
10.1016/S0047-6374(03)00004-6
10.1016/S0021-9150(97)00194-9
10.4049/jimmunol.172.8.4681
10.4049/jimmunol.164.8.4286
10.1016/S0531-5565(01)00179-6
10.1146/annurev.physiol.60.1.619
Kurt‐Jones EA, 2002, Role of toll‐like receptor‐2 (TLR2) in neutrophil activation: GM‐CSF enhances TLR2 expression and TLR2‐mediated interleukin responses in neutrophils, Blood, 100, 1860, 10.1182/blood.V100.5.1860.h81702001860_1860_1868
10.1016/j.exger.2003.10.031
10.7326/0003-4819-109-2-127
10.1016/0047-6374(90)90108-R
10.1016/S0047-6374(01)00285-8
10.1016/S0065-2776(08)60047-4
10.1056/NEJM200008033430506
10.1016/S0047-6374(98)00065-7
10.1016/0024-3205(89)90482-7
10.1016/S0165-2478(02)00210-9
10.4049/jimmunol.169.9.4697
10.1016/0047-6374(80)90088-3
Rossi AG, 1994, Immunopharmacology of Neutrophils, 223
10.1016/S0014-5793(98)00004-0
10.1002/j.1460-2075.1993.tb06102.x
10.1016/S0047-6374(03)00017-4
10.1016/0047-6374(93)90042-P
10.1016/S0014-5793(03)00845-7
10.1034/j.1600-065X.2003.00038.x
Tortorella C, 2001, Neutrophil apoptotic cell death: does it contribute to the increased infectious rsik in aging?, Microbios, 106, 129
10.1016/S0047-6374(99)00055-X
10.1016/0047-6374(90)90144-5
10.1016/0014-5793(89)81602-3
10.1016/S0531-5565(97)00042-9
10.1016/S0009-9120(88)80101-2
10.1016/0014-5793(92)80781-B
10.1016/S0531-5565(96)00156-8
Watanabe S, 1997, Roles of JAK kinase in human GM‐CSF receptor signals, Leukemia, 11, 76
10.1016/S0301-472X(99)00040-5
Yamamoto K, 1999, Neutrophil function, Jap. J. Clin. Med., 57, 524
Zu YL, 1998, p38 mitogen‐activated protein kinase activation is required for human neutrophil function triggered by TNF‐alpha or FMLP stimulation, J. Immunol., 160, 1982, 10.4049/jimmunol.160.4.1982